Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?

Berna Kömürcüoglu, Yelda Vatansever, Esra Korkmaz, Aysen Evkan, Enver Yalniz
European Respiratory Journal 2016 48: PA4843; DOI: 10.1183/13993003.congress-2016.PA4843
Berna Kömürcüoglu
1Torasic Oncology, Dr.Suat Seren Education and Resarch Hospital for Chest Disease, Izmir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yelda Vatansever
1Torasic Oncology, Dr.Suat Seren Education and Resarch Hospital for Chest Disease, Izmir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esra Korkmaz
2Radiation Oncology, Dr.Suat Seren Education and Resarch Hospital for Chest Disease, Izmir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aysen Evkan
1Torasic Oncology, Dr.Suat Seren Education and Resarch Hospital for Chest Disease, Izmir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enver Yalniz
1Torasic Oncology, Dr.Suat Seren Education and Resarch Hospital for Chest Disease, Izmir, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Aim: Lung cancer remains the leading cause of cancer-related deaths worldwide. Number of studies have focused on exploring the efficacy of consolidation chemotherapy (CCT) following concurrent CRT to improve survival. But these studies have discordant results. For patients with LA-NSCLC the efficacy and safety of consolidation chemotherapy (CCT) following concurrent chemoradiotherapy (CRT) is not well defined. Therefore, the aim of this study was to evaluate the efficacy and toxicity of CCT.

Methods: We retrospectively analysed the clinical records of LA-NSCLC patients treated with concurrent CRT as an initial treatment at our Chest Diseases Hospital between January 2010 and January 2014. All patients were cyto-histologically proven NSCLC and clinically diagnosed as stage III according to the American Joint Committee on Cancer (AJCC) 2009 staging system. All patients treated with curative thoracic radiotherapy with concurrent platinum doublet chemotherapy. We investigated the overall survival (OS) and progression-free survival (PFS) on exploring the efficacy of consolidation chemotherapy (CCT) following concurrent CRT to improve survival.

Results: 63 LA-NSCLC patients were participated in the study (6 female, 57 male). The median OS is 18 (95% CI) and the median PFS is 9 (95% CI) months. The detailed datas will be presented during the congress.

  • Lung cancer / Oncology
  • Neoplastic diseases
  • Thoracic oncology
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Berna Kömürcüoglu, Yelda Vatansever, Esra Korkmaz, Aysen Evkan, Enver Yalniz
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4843; DOI: 10.1183/13993003.congress-2016.PA4843

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Berna Kömürcüoglu, Yelda Vatansever, Esra Korkmaz, Aysen Evkan, Enver Yalniz
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4843; DOI: 10.1183/13993003.congress-2016.PA4843
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • LATE-BREAKING ABSTRACT: Early relapse of non-small cell lung cancer (NSCLC) found after CNS-symptoms
  • Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
  • Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
Show more 11.1 Lung Cancer

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society